After more than 15 years, the battle between the Canada Revenue Agency and Glaxo Canada over the transfer price for ranitidine—the active pharmaceutical ingredient used to make the branded, anti-ulcer drug Zantac—finally reached the Supreme Court of Canada (SCC) last month.
Anna Soubbotina featured in Women of IFA Network (WIN) USA Newsletter
CRA Transfer Pricing Principal Anna Soubbotina is featured in the recent Women of IFA Network (WIN) USA Newsletter. Ms. Soubbotina is a regional co-leader of...